News Focus
News Focus
icon url

misiu143

03/08/21 2:23 AM

#151303 RE: CTMedic #151301

CTMedic , what a great read , I hope everyone will read to the end ..

Thank you
icon url

Latane

03/08/21 6:02 AM

#151315 RE: CTMedic #151301

Awesome Post!
icon url

erik007tc

03/08/21 6:22 AM

#151320 RE: CTMedic #151301

Awesome!
icon url

Rockleo

03/08/21 6:57 AM

#151323 RE: CTMedic #151301

CTMEDIC..Incredible..Great job..!!!!
icon url

ClosetInvestor

03/08/21 7:43 AM

#151333 RE: CTMedic #151301

“Approval would have likely been this week had they simply recommended they change the primary endpoint to what everyone else was doing, but the DSMC made a huge blunder that could ultimately cost tens of thousands of American lives.”

Is this article a joke? The DSMC did not instruct CYDY to finish the trial, they told NP at 50% to conduct another analysis at 75%. This “article” appears to be written by an investor who doesn’t understand the clinical trial process. The blame for the failure of CD12 is on the Shoulders of NP, not the DSMC.
icon url

bluefish1

03/08/21 8:58 AM

#151363 RE: CTMedic #151301

This is what a lifesaving treatment looks like.



This is what fraud looks like.

https://seekingalpha.com/article/4412192-cytodyn-parsing-failure#comments

See the difference?

Thanks to CTMedic for posting the image.

icon url

Hookmeistr

03/08/21 11:07 AM

#151441 RE: CTMedic #151301

CTMedic, wow, great read. Thanks for putting that together. I was having a difficult time trying to put it all together in a way that I could understand it and what you did really helped. I appreciate it.
icon url

clambottler

03/08/21 11:12 AM

#151444 RE: CTMedic #151301

CT Medic So What is the Population In Need ?

CYDY wants only critical patients
over 65
on ventilators ?

With the Vaccines

With the New Standard of Care ( SOC ) using sterioids and HFNC High Flow Nasal Cannula Not Ventilators

With several or more competitors in trial
some just coming out of trials
some Sponsored by I SPY and NIH


What is the Patient Population In Need
and Available for Trial ???


AND WHY DIDN'T CYDY GET INCLUDED IN ANY OF THOSE GOVERNMENT TRIALS ??????????????


WOW I would really like to get an understanding on that.

Why On Earth is CYDY Not being sponsored by the Government ????
Not included in ANY trials ????

xxx.
xx.
x.
icon url

Bourbon_on_my_cornflakes

03/08/21 12:50 PM

#151494 RE: CTMedic #151301

Does Janet Woodcock have the stones?

Janet Woodcock, the new chief, has the power to look at secondary endpoints. CytoDyn gave them a huge statistically significant endpoint... the subgroup, which represents 80% of the clinical trial, was statistically relevant and met the primary endpoint with a p=.0319. In other words they crushed the endpoint.

t this point in the pandemic it will be interesting to see if the newly anointed FDA chief follows her own guidance... They are also recommending time to sustained recovery as a primary endpoint. CytoDyn also announced this weekend the discharged alive endpoint at Day 28. It showed leronlimab was 166% better than the placebo arm with a 28% probability of walking out of the hospital versus an 11% chance of walking out of the hospital.
icon url

Learning53

03/09/21 1:31 AM

#151749 RE: CTMedic #151301

Re the Leronlimab results: Appreciate the in depth analysis
Thank you